Literature DB >> 10721503

Automated docking and molecular dynamics simulations of nimesulide in the cyclooxygenase active site of human prostaglandin-endoperoxide synthase-2 (COX-2).

R García-Nieto1, C Pérez, F Gago.   

Abstract

Molecular models of the complex between the selective COX-2 inhibitor nimesulide and the cyclooxygenase active site of human prostaglandin-endoperoxide synthase-2 have been built using a combination of homology modelling, conformational searching and automated docking techniques. The stability of the resulting complexes has been assessed by molecular dynamics simulations and interaction energy decomposition. It is found that nimesulide exploits the extra space made available by the replacement at position 523 of an isoleucine residue in COX-1 by a valine in COX-2 and establishes electrostatic interactions with both Arg-106 and Arg-499 (Arg-120 and Arg-513 in PGHS-1 numbering). Two alternate binding modes are proposed which are compatible with the pharmacological profile of this agent as a COX-2 selective inhibitor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10721503     DOI: 10.1023/a:1008110924479

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  45 in total

1.  Interactions of some PGHS-2 selective inhibitors with the PGHS-1: an automated docking study by BioDock.

Authors:  A Pedretti; A M Villa; L Villa; G Vistoli
Journal:  Farmaco       Date:  1997 Jun-Jul

2.  1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents.

Authors:  I K Khanna; R M Weier; Y Yu; X D Xu; F J Koszyk; P W Collins; C M Koboldt; A W Veenhuizen; W E Perkins; J J Casler; J L Masferrer; Y Y Zhang; S A Gregory; K Seibert; P C Isakson
Journal:  J Med Chem       Date:  1997-05-23       Impact factor: 7.446

3.  Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.

Authors:  R G Kurumbail; A M Stevens; J K Gierse; J J McDonald; R A Stegeman; J Y Pak; D Gildehaus; J M Miyashiro; T D Penning; K Seibert; P C Isakson; W C Stallings
Journal:  Nature       Date:  1996 Dec 19-26       Impact factor: 49.962

4.  A new method for predicting binding affinity in computer-aided drug design.

Authors:  J Aqvist; C Medina; J E Samuelsson
Journal:  Protein Eng       Date:  1994-03

5.  The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.

Authors:  G M Greig; D A Francis; J P Falgueyret; M Ouellet; M D Percival; P Roy; C Bayly; J A Mancini; G P O'Neill
Journal:  Mol Pharmacol       Date:  1997-11       Impact factor: 4.436

6.  Role of Val509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents.

Authors:  Q Guo; L H Wang; K H Ruan; R J Kulmacz
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

7.  Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice.

Authors:  M Fukutake; S Nakatsugi; T Isoi; M Takahashi; T Ohta; S Mamiya; Y Taniguchi; H Sato; K Fukuda; T Sugimura; K Wakabayashi
Journal:  Carcinogenesis       Date:  1998-11       Impact factor: 4.944

8.  NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

Authors:  N Futaki; S Takahashi; M Yokoyama; I Arai; S Higuchi; S Otomo
Journal:  Prostaglandins       Date:  1994-01

9.  Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1.

Authors:  D K Bhattacharyya; M Lecomte; C J Rieke; M Garavito; W L Smith
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

10.  Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  E Okajima; A Denda; S Ozono; M Takahama; H Akai; Y Sasaki; W Kitayama; K Wakabayashi; Y Konishi
Journal:  Cancer Res       Date:  1998-07-15       Impact factor: 12.701

View more
  5 in total

1.  An insight into the sequential, structural and phylogenetic properties of banana 1-aminocyclopropane-1-carboxylate synthase 1 and study of its interaction with pyridoxal-5'-phosphate and aminoethoxyvinylglycine.

Authors:  Swarup Roy Choudhury; Sanjay Kumar Singh; Sujit Roy; Dibyendu N Sengupta
Journal:  J Biosci       Date:  2010-06       Impact factor: 1.826

2.  Docking studies on NSAID/COX-2 isozyme complexes using contact statistics analysis.

Authors:  Giuseppe Ermondi; Giulia Caron; Raelene Lawrence; Dario Longo
Journal:  J Comput Aided Mol Des       Date:  2004-11       Impact factor: 3.686

3.  Free energy perturbation approach to the critical assessment of selective cyclooxygenase-2 inhibitors.

Authors:  Hwangseo Park; Sangyoub Lee
Journal:  J Comput Aided Mol Des       Date:  2005-01       Impact factor: 3.686

4.  Molecular dynamics simulations of arachidonic acid complexes with COX-1 and COX-2: insights into equilibrium behavior.

Authors:  Kristina E Furse; Derek A Pratt; Ned A Porter; Terry P Lybrand
Journal:  Biochemistry       Date:  2006-03-14       Impact factor: 3.162

5.  Binding modes of peptidomimetics designed to inhibit STAT3.

Authors:  Ankur Dhanik; John S McMurray; Lydia E Kavraki
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.